Method for multifragment in vivo cloning and mutation mapping

• US 5,976,846 A
• Filed: 01/13/1996
• Issued: 11/02/1999
• Est. Priority Date: 01/13/1996
• Status: Expired due to Fees

• Current Assignee: Optagen Biotechnology, LLC
• Original Assignee: Donna L. Marykwas, Steven E. Passmore
• Inventors: Marykwas, Donna L., Passmore, Steven E.
• Primary Examiner(s): Jones, W. Gary
• Assistant Examiner(s): WHISENANT, ETHAN C
• Application Number:
  US08/584,322
• Time in Patent Office: 1,389 Days
• Field of Search: 435/172.3, 435/91.2, 435/6
• US Class Current: 435/483
• CPC Class Codes: C12N 15/10 Processes for the isolation, preparation or purification of DNA or RNA chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34
• CPC Class Codes: C12N 15/64 General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

Abstract

The subject invention relates to a method referred to as multifragment in vivo cloning (MFIVC). In the method, the polymerase chain reaction or the cleavage by restriction enzyme(s) are used to generate a series of double-stranded DNA fragments. Each fragment contains a region homologous to a portion of the fragment to which it is to be joined. These homologous regions undergo recombination in vivo following transformation into a host with efficient and precise homologous recombination (such as the yeast S. cerevisiae). A series is designed so that the last fragment in the series contains a region homologous to a portion of the first fragment in the series, thus forming a circular DNA molecule after recombination in vivo. A circular DNA molecule can be selected in vivo if the circular DNA molecule created contains both a suitable DNA replication origin and a suitable marker for genetic selection. A series may be designed so that the first and last fragment in the series contain telomeric sequence elements, forming a linear DNA molecule with telomeric sequence elements at its ends, after recombination in vivo. One preferred embodiment of this method includes a means for mapping a phenotypically expressed mutation within a gene. A second embodiment of this method includes a means for constructing plasmids using DNA cassettes. A third embodiment of this method includes a means of reasserting mutations in a double-stranded DNA molecule. The invention also includes kits containing reagents for conducting the method.

Claims

1. A method for synthesizing a double-stranded circular DNA molecule, the method comprising the steps of:

(i) in a first container means, amplifying from a first double-stranded circular DNA molecule a first double-stranded DNA segment by means of a polymerase chain reaction (PCR) process, wherein a plurality of primers are provided so that two primers effect the amplification and one primer adds a nucleotide sequence to the first segment, the sequence being homologous to a second double-stranded DNA segment to which the first segment is to be joined;

(ii) in a second container means, amplifying from a second double-stranded circular DNA molecule a second double-stranded DNA segment by means of the PCR process, wherein a plurality of primers are provided so that two primers effect the amplification and one primer adds a nucleotide sequence to the second segment, the sequence being homologous to a third double-stranded DNA segment to which the second segment is to be joined;

(iii) in a third container means amplifying from a third double-stranded circular DNA molecule a third double-stranded DNA segment by means of the PCR process, wherein a plurality of primers are provided so that two primers effect the amplification and one primer adds a nucleotide sequence to the third segment, the sequence being homologous to the first double-stranded DNA segment to which the third segment is to be joined;

(iv) transforming the product of step (i), and the product of step (ii), and the product of step (iii) together into a host with a suitable, efficient, and accurate in vivo recombination system; and

(v) allowing the product of step (ii) to recombine in vivo at the homologous sequence added to the product of step (i), allowing the product of step (iii) to recombine at the homologous sequence added to the product of step (ii), and allowing the product of step (i) to recombine at the homologous sequence added to the product of step (iii), thereby producing a fourth double-stranded circular DNA molecule.

2. The method of claim 1 wherein the host is yeast.

3. The method of claim 1 wherein at least one homologous sequence added to one double-stranded DNA segment in steps (i), (ii) and (iii) is located at one end of the DNA segment.

4. The method of claim 1 wherein at least one homologous sequence added to one double-stranded DNA segment in steps (i), (ii) and (iii) is located between two opposing ends of the DNA segment.

5. The method of claim 1 wherein

(i) the first double-stranded DNA segment contains in vivo selection means;

and

(ii) the second double-stranded DNA segment contains in vivo DNA replication means, so as to provide the doubled-stranded circular DNA molecule produced in step (v) in vivo selection means, and in vivo DNA replication means.

6. The method of claim 1 wherein prior to the step of transforming in step (iv), at least one additional double-stranded DNA segment is amplified from at least one additional double-stranded DNA molecule by means of the PCR process to include at one end a nucleotide sequence that is homologous to a sequence in a DNA segment to which said at least one additional DNA segment is to be joined, such that said at least one additional double-stranded DNA segment is subsequently transformed into the host in step (iv) and recombined in step (v) along with the products of steps (i), (ii), and (iii).

7. The method of claim 6 wherein said at least one additional DNA segment further includes a homologous sequence at an end opposite the one end.

9. The method of claim 6 wherein at least one of said at least one additional double-stranded DNA molecule is a linear DNA molecule.

10. The method of claim 6 wherein at least one of said at least one additional double-stranded DNA molecule is a circular DNA molecule.

11. The method of claim 3 wherein the step of amplifying in steps (i), (ii) and (iii) further includes adding a homologous sequence to an opposite end of the DNA segment by means of a primer different from the primer adding the nucleotide sequence to the one end of the DNA segment.

8. A method for synthesizing a double-stranded circular DNA molecule, the method comprising the steps of:

(i) in a first container means, amplifying from a first double-stranded DNA molecule a first double-stranded DNA segment by means of a polymerase chain reaction (PCR) process, wherein a plurality of primers are provided so that two primers effect the amplification, the first segment having a nucleotide sequence that is homologous to a sequence in a second double-stranded DNA segment to which the first segment is to be joined;

(ii) in a second container means, amplifying from a second double-stranded DNA molecule the second double-stranded DNA segment by means of the PCR process, wherein a plurality of primers are provided so that two primers effect the amplification, the second segment having a nucleotide sequence that is homologous to a sequence in a third double-stranded DNA segment to which the second segment is to be joined;

(iii) in a third container means, amplifying from a third double-stranded DNA molecule the third double-stranded DNA segment by means of the PCR process, wherein a plurality of primers are provided so that two primers effect the amplification, the third segment having a nucleotide sequence that is homologous to a sequence in the first double-stranded DNA segment to which the third segment is to be joined;

wherein the first, second, and third double-stranded DNA molecules are different from one another and at least one of the first, second, and third double-stranded DNA molecules is linear;

(iv) transforming the product of step (i), and the product of step (ii), and the product of step (iii) together into a host with a suitable, efficient, and accurate in vivo recombination system; and

(v) allowing the product of step (ii) to recombine in vivo at the homologous sequence added to the product of step (i), allowing the product of step (iii) to recombine at the homologous sequence added to the product of step (ii), and allowing the product of step (i) to recombine at the homologous sequence added to the product of step (iii), thereby producing a double-stranded circular DNA molecule.

12. The method of claim 8 wherein the homologous sequence in each double-stranded DNA segment in steps (i), (ii) and (iii) is located at one end of the DNA segment.

13. The method of claim 12 wherein the step of amplifying in steps (i), (ii) and (iii) further includes adding a homologous sequence to an opposite end of the DNA segment by means of a primer different from the primer adding the nucleotide sequence to the one end of the DNA segment.

14. The method of claim 8 wherein the homologous sequence in each double-stranded DNA segment in steps (i), (ii) and (iii) is located between two opposing ends of the DNA segment.

15. The method of claim 8 wherein prior to the step of transforming in step (v), at least one additional double-stranded DNA segment is amplified from at least one additional DNA molecule by means of the PCR process to include a nucleotide sequence that is homologous to a sequence in a DNA segment to which said at least one additional DNA segment is to be joined, such that said at least one additional double-stranded DNA segment is subsequently transformed into the host in step (iv) and recombine in step (v) along with the products of steps (i), (ii), and (iii).